Grace Therapeutics
GRCE
11 hedge funds and large institutions have $3.18M invested in Grace Therapeutics in 2015 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 7 closing their positions.
12% less capital invested
Capital invested by funds: $3.63M → $3.18M (-$450K)
35% less funds holding
Funds holding: 17 → 11 (-6)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AGM
Alpine Global Management
New York
|
+$4.94K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$471 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$102K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$92.7K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$82K |
| 4 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$54.4K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$20K |
GRCE Hedge Fund Activity: Q1 2015 in Review
11 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q1 2015, worth a combined $3.18M — down 12% from $3.63M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of GRCE and 1 opened new positions — a net loss of 6 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was Alpine Global Management, opening a new position worth an estimated $4.94K. The largest seller was Perceptive Advisors, cutting an estimated $102K.
- 11 institutional investors held Grace Therapeutics (GRCE) as of Q1 2015, down from 17 in Q4 2014.
- Funds reported $3.18M of Grace Therapeutics stock for Q1 2015, down 12% quarter-over-quarter.
- 1 fund opened new Grace Therapeutics positions in Q1 2015 and 7 closed out, a net change of -6 holders.
- The largest Grace Therapeutics buyer in Q1 2015 was Alpine Global Management, an estimated $4.94K added.
- The largest Grace Therapeutics seller in Q1 2015 was Perceptive Advisors, an estimated $102K sold.
Based on aggregated 13F filings for Q1 2015.